Altai Announces Senior Management Addition
Ms. Silina holds a Diploma in Management Studies from Thompson Rivers University and is currently a Senior Accountant at Da Costa Management Corp., where she provides financial consulting and outsourced CFO services to both public and private companies.
Ms. Silina also serves as the CFO of StimCell Energetics Inc., Stuhini Exploration Ltd., Tocvan Ventures Corp, and Cascade Copper Corp. In addition, she is a Director of Kesselrun Resources Ltd.
ABOUT ALTAIAltai Resources Inc. is a Toronto, Ontario based resource company with a producing oil property in Alberta, an exploration gold property in Quebec, and a Canadian investment portfolio comprised of cash, cash equivalents, and marketable securities. Additional information about Altai is available on SEDAR+ at www.sedarplus.ca and on Altai's website at www.altairesources.com.
For further information, please contact:Kursat Kacira, Chairman & CEO/PresidentT: (647) 282-8324, E: kursatkacira@altairesources.ca
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Solstice Gold Makes New Discovery Intersecting 8.52 g/t Au over 3.5m at the Strathy Gold Project in NE Ontario
VANCOUVER, British Columbia--(BUSINESS WIRE)--Solstice Gold Corp. (TSXV: SGC) ('Solstice', 'we', 'our' or the 'Company') is pleased to report assay results from its Spring 2025 drill program (3,120 metres in 13 holes) which includes the Red Cedar Discovery, intersecting 8.52 g/t Au over 3.5m including 28.7 g/t over 1.0m in hole SGPDH25-09, in a previously untested area of the Strathy Gold Project (the 'Project'). The Project is located in the Temagami Greenstone Belt in the prolific Abitibi Subprovince in Ontario. Details of assay results are provided below in Table 1. Solstice's very first drill program at Strathy has delivered a brand-new high-grade discovery in a target zone that's wide open for expansion. Share Spring 2025 Drill Program Highlights Pablo McDonald, Solstice CEO stated, ' Our very first drill program at Strathy has delivered a brand-new high-grade discovery in a target zone that's wide open for expansion. We've also confirmed that the Leckie Fault is a gold-bearing structure with kilometre-scale potential. With more than 30 IP anomalies still to test, plus newly acquired adjacent claims, we're only scratching the surface in this underexplored part of the legendary Abitibi. The stage is set for aggressive follow-up drilling and multiple discovery opportunities. ' Solstice plans follow-up drilling focused on expanding the Red Cedar Discovery, targeting extension of its associated 300x500m IP anomaly. Additional drilling will test down-dip expansion of the Leckie Gold Zone, which contains high-grade, shallow-depth historic intercepts on Solstice claims which can be accessed using ice-based drilling. By advancing two compelling, high-grade targets, Solstice aims to significantly increase the potential for adding additional high-grade intercepts on the Strathy Gold Project. Solstice also plans to extend IP surveys to cover an additional 35% of its core claims. Figure 1: Map of all drillholes on the Spring 2025 drill campaign. Targets 2 and 3 represent the North and South extension of the gold-bearing Leckie Fault. Table 1: Drill Results (Gold) Table 2: Drill Results (Base Metals) Hole Easting Northing Depth Azimuth Dip Comment SGPDH25-01 591023 5216571 190 60 -45 68.70m @ 1358.69ppm Ni + Cu (acid soluble) in ultramafic SGPDH25-03 591051 5216521 271 57 -62 42.17m @ 1048.05 Ni + Cu ppm (acid soluble) in ultramafic and 10.50m @ 1245ppm Ni + Cu (acid soluble) in ultramafic SGPDH25-11 590549 5216398 286 306 -45 7.00m @ 1198.93ppm Ni + Cu (acid soluble) and 13.00m @ 1048.08 Ni + Cu (acid soluble) *Reported widths are core lengths, true widths not known Expand QA/QC Procedures All ½ NQ drill core samples were collected in a secure location, placed into sealed bags and shipped to Activation Laboratories Ltd. ("ActLabs") in North Bay, Ontario. A series of industry standard internal quality control and assurance programs were followed, which included security tags on all shipments and the insertion of certified reference materials, duplicates (¼ core) and blank samples in regular intervals. Samples were processed at the lab for gold analysis by a 50-gram fire assay with finish by atomic absorption as well as 1,000-gram fire assay with metallic screen (package 1A4–1000) for samples with >0.1g/t Au FA. Multi-element analysis was done using aqua regia digestion (package 1E3–ICP). A total of 57 high sulphide or arsenic samples were run as check fire assays using modified flux by Actlabs and or photon assay. Six of the reanalyses returning results with a variance of between +92% and 331% compared to the original metallic assay. Twenty-three high Ni-Cr-Cu samples (combined >2,000ppm) were analyzed for gold using NiS FA at ActLabs, with five samples returning between +60% to +697% compared to 2x detection limit of original metallics assays (60ppb). Taken together, these re-assays suggest that further investigation regarding the accurate determination of gold contents of certain samples may be justified. Analytical results passed internal QA/QC review. Some standards were within ranges requiring closer review but given the scale and general consistency of QA/QC analysis, the Company deems these exceptions to be insignificant. ActLabs is independent of Solstice. About the Strathy Gold Project The Strathy Gold Project is an extensive 41 km 2 land package in the Archean-age Temagami Greenstone Belt, which is the southernmost extension of the Abitibi Subprovince in Ontario. Located on the Trans Canada Highway, the project has excellent access to infrastructure and mining expertise. The Project includes parts of the Net-Vermilion Deformation Zone and the Link Lake Deformation Zone, which are two prominent Northeast-Southwest-trending structures crosscutting Archean metavolcanics. It contains documented, widespread high-grade gold mineralization, hosting historic intercepts of 5.00 g/t Au over 17.28m and 7.66 g/t Au over 7.25m (core lengths) at vertical depths of approximately 50-100 metres below surface 1, and documented surface sample results of up to 62.7 g/t Au 2. Despite this demonstrated prospectivity, the core claims at Strathy have not been systemically explored in the past. For more detailed information on the Project, including a technical review of the project and a detailed review of IP results and targeting, please visit References: OGS Assessment file No. 31M04SW0088 Wabana Exploration Assessment Report, file No. 31M04SE2005 About Solstice Gold Corp. Solstice is an exploration company with quality, district-scale gold projects in established mining regions of Canada. Our 41 km 2 Strathy Gold Project hosts high grade gold mineralization over a wide area straddling two NE-SW-trending structures. It is located in the Abitibi Subprovince of the Superior Craton and has never been systematically explored in its history. Our Qaiqtuq Gold Project which covers 662 km 2, hosts a 10 km 2 high grade gold boulder field, is fully permitted and hosts multiple drill-ready targets. Qaiqtuq is located in Nunavut, only 26 km from Rankin Inlet and approximately 7 km from the Meliadine Gold Mine owned by Agnico Eagle Mines Limited. Our district-scale Atikokan Gold Project is approximately 26 km from the Hammond Reef Gold Project owned by Agnico Eagle Mines Limited. Our 194 km 2 Red Lake Extension (RLX) and New Frontier projects are located at the northwestern extension of the prolific Red Lake Camp in Ontario and approximately 45 km from the Red Lake Mine Complex owned by Evolution Mining. An extensive gold and base metal royalty and property portfolio of over 80 assets was purchased in October 2021. Well over $2.5 million in value and over 25 new royalties have been generated since the acquisition. Solstice is committed to responsible exploration and development in the communities in which we work. For more details on Solstice Gold, our exploration projects and details on our portfolio of projects please see our Corporate Presentation available at Solstice's Chairman, David Adamson, was a co-award winner for the discovery of Battle North Gold Corporation's Bateman Gold deposit and was instrumental in the acquisition of many of the district properties in the Battle North portfolio during his successful 16 years of exploration in the Red Lake. Sandy Barham, Senior Geologist, is the Qualified Person as defined by NI 43-101 standards responsible for reviewing and approving the technical disclosures of this news release. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements and Additional Cautionary Language This news release contains certain forward-looking statements ('FLS') including, but not limited to the need for more prospecting and analysis, that the geological and structural setting at the Strathy Gold Project is highly prospective for gold mineralization, defining drill targets, the focus of follow-up efforts on drill holes, promising geochemical and mineralogical anomalies, further evaluation and modelling following completion of drill hole compilation. FLS can often be identified by forward-looking words such as 'approximate or (~)', 'emerging', 'goal', 'plan', 'intent', 'estimate', 'expects', 'potential', 'scheduled', 'may' and 'will' or similar words suggesting future outcomes or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. In respect of the FLS, the Company has made certain assumptions that management believes are reasonable at this time. The assumptions include that the Company will have sufficient financial resources for further geological exploration this year, that gold discoveries will be to the level anticipated however, there can be no assurance that such assumptions and statements will prove to be accurate and actual results could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from any FLS include, but are not limited to, limited capital or access to additional capital for prospecting, delays in obtaining or failures to obtain required TSXV, governmental, environmental or other project approvals, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects, regulatory approvals and other factors. FLS are subject to risks, uncertainties and other factors that could cause actual results to differ materially from expected results. Potential shareholders and prospective investors should be aware that these statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those suggested by the FLS. Shareholders are cautioned not to place undue reliance on FLS. By their nature FLS involve numerous assumptions, inherent risks and uncertainties, both general and specific that contribute to the possibility that the predictions, forecasts, projections and various future events will not occur. Solstice undertakes no obligation to update publicly or otherwise revise any FLS whether as a result of new information, future events or other such factors which affect this information, except as required by law. Historical Sampling and Drilling Data and Information The sampling and drilling data and information presented in this news release (the 'Historical Exploration Information') is historical in nature. The reader is cautioned that the Historical Exploration Information is based on prior data and reports previously prepared by third parties without the involvement of Solstice. Solstice has not undertaken any independent investigation, nor has it independently analyzed the results of the Historical Exploration Information in order to verify the results. The reader is cautioned not to treat Historical Exploration Information, or any part of it, as current and that a qualified person has not done sufficient work to verify the results and that they may not form a reliable guide to future results. No independent quality assurance/quality control protocols are known for these historic samples and drill holes and therefore the Historical Exploration Information may be unreliable. Solstice considers these historical drill results relevant as the Company will use this data as a guide to plan future exploration and drilling programs. Solstice considers the data to be reliable for these purposes, however, the Company's future exploration work will include verification of the data through drilling.
Business Wire
an hour ago
- Business Wire
Arizona Sonoran Completes 0.64% Buy-down of Cactus Project Royalties
CASA GRANDE, Ariz. & TORONTO--(BUSINESS WIRE)-- Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) ('ASCU' or the 'Company'), an emerging U.S. copper developer, is pleased to announce that further to its June 25, 2025 press release, ASCU has completed the 0.64% buy-down of certain net smelter returns royalties on the Cactus Project (collectively, the 'NSRs'; see FIGURE 1 – ' 2025 Royalty Map'). Following execution of definitive documentation, total cash payments of US$8.91 million were made to RG Royalties, LLC, a subsidiary of Royal Gold Inc. (RLGD:NASDAQ) and Elemental Royalties Delaware LLC, a subsidiary of Elemental Altus Royalties Corp. (ELE:TSXV), upon which the aggregate percentage of the NSRs was reduced from 3.18% to a remaining 2.54% (collectively, the 'Buy-downs'). The completion of the Buy-downs is a natural step for the Company to generate potential additional shareholder value and reduce economic encumbrance on the asset as we advance towards project financing. Share Nick Nikolakakis, Arizona Sonoran Chief Financial Officer and VP Finance commented, 'Management's focus is driven by delivering copper price exposure and potential upside to our shareholders. The completion of the Buy-downs is a natural step for the Company to generate potential additional shareholder value and reduce economic encumbrance on the asset as we advance towards project financing. In particular, the 2024 PEA demonstrated that the $8.91 million expenditure to complete the Buy-downs improves the Cactus Project valuation at variety of long‑term copper price forecasts and, therefore, increases shareholder value, now and in the long run.' The Company's subsidiaries, Cactus 110 LLC and Arizona Sonoran Copper Company USA Inc., following execution of definitive documentation, have completed the Buy-downs as follows: (i) Royal Gold's 2.5% NSR to 2.0% for US$7.0 million and (ii) Elemental Altus' 0.68% NSR to 0.54% for US$1.91 million. Neither the TSX nor the regulating authority has approved or disproved the information contained in this press release. Links from the PR: FIGURE 1: '2025 Royalty Map' June 25, 2025 Press Release: About Arizona Sonoran Copper Company ( | ASCU is a copper exploration and development company with a 100% interest in the brownfield Cactus Project. The Project, on privately held land, contains a large-scale porphyry copper resource and a recent 2024 PEA proposes a generational open pit copper mine with robust economic returns. Cactus is a lower risk copper developer benefitting from a State-led permitting process, in place infrastructure, highways and rail lines at its doorstep and onsite permitted water access. The Company's objective is to develop Cactus and become a mid-tier copper producer with low operating costs, that could generate robust returns and provide a long-term sustainable and responsible operation for the community, investors and all stakeholders. The Company is led by an executive management team and Board which have a long-standing track record of successful project delivery in North America complemented by global capital markets expertise. Cautionary Statements regarding Forward-Looking Statements and Other Matters Forward-Looking Statements All statements, other than statements of historical fact, contained or incorporated by reference in this press release constitute 'forward-looking statements' and 'forward-looking information' (collectively, 'forward-looking statements') within the meaning of applicable Canadian and United States securities legislation. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as 'anticipated', 'assumptions', 'become', 'believes', 'conceptual', 'could', 'delivering', 'developer', 'emerging', 'estimates', 'exploration', 'expectation', 'focus', 'future', 'generational', 'later', 'long-term', 'objectives', 'options', 'potential', 'proposes', 'risk', 'subject to', 'towards', 'upside', and 'will', or variations of such words, and similar such words, expressions or statements that certain actions, events or results can, could, may, should, would, will (or not) be achieved, occur, provide, result or support in the future, or which, by their nature, refer to future events. In some cases, forward-looking information may be stated in the present tense, such as in respect of current matters that may be continuing, or that may have a future impact or effect. Forward-looking statements include those relating to the implications of the Buy-downs (including impacts on the valuation and other economics of the Cactus Project, and any resulting shareholder value or upside related to such Buy-downs); management's focus and any delivery of copper price exposure and potential upside to shareholders; ); project financing; the 2024 PEA and results thereof (including risk, economic returns, operating costs, production, and proposal of a generational open pit copper mine); and the Company's objectives (including development of the Cactus Project, becoming a mid-tier copper producer with low operating costs, that could generate robust returns and provide a long-term sustainable and responsible operation for the community, investors and all stakeholders, and any other continuing or future successes). Although the Company believes that such statements are reasonable, there can be no assurance that those forward-looking statements will prove to be correct, and any forward-looking statements by the Company are not guarantees of future actions, results or performance. Forward-looking statements are based on assumptions, estimates, expectations and opinions, which are considered reasonable and represent best judgment based on available facts, as of the date such statements are made. If such assumptions, estimates, expectations and opinions prove to be incorrect, actual and future results may be materially different than expressed or implied in the forward-looking statements. The assumptions, estimates, expectations and opinions referenced, contained or incorporated by reference in this press release which may prove to be incorrect include those set forth or referenced in this press release, as well as those stated in the Company's prior press releases referenced herein (collectively, the 'Referenced PRs'), the technical report for the Cactus Project filed on August 27, 2024 (the '2024 PEA Technical Report'), the Company's Annual Information Form dated March 27, 2025 (the 'AIF'), Management's Discussion and Analysis (together with the accompanying financial statements) for the year ended December 31, 2024 and the quarters already ended in 2025 (collectively, the '2024-25 Financial Disclosure') and the Company's other applicable public disclosure (collectively, 'Company Disclosure'), all available on the Company's website at and under its issuer profile at Forward-looking statements are inherently subject to known and unknown risks, uncertainties, contingencies and other factors which may cause the actual results, performance or achievements of ASCU to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks, uncertainties, contingencies and other factors include, among others, the 'Risk Factors' in the AIF, and the risks, uncertainties, contingencies and other factors identified in the Referenced PRs, the 2024 PEA Technical Report and the 2024-25 Financial Disclosure. The foregoing list of risks, uncertainties, contingencies and other factors is not exhaustive; readers should consult the more complete discussion of the Company's business, financial condition and prospects that is provided in the AIF, the 2024-25 Financial Disclosure and other Company Disclosure. Although ASCU has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Forward-looking statements contained herein are made as of the date of this press release (or as otherwise expressly specified) and ASCU disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from forward-looking statements. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements referenced or contained in this press release are expressly qualified by these Cautionary Statements as well as the Cautionary Statements in the AIF, the Referenced PRs, the 2024 PEA Technical Report and the 2024-25 Financial Disclosure. Preliminary Economic Assessments The Preliminary Economic Assessment (or 2024 PEA) referenced in this press release and summarized in the 2024 PEA Technical Report is only a conceptual study of the potential viability of the Cactus Project and the economic and technical viability of the Cactus Project has not been demonstrated. The 2024 PEA is preliminary in nature and provides only an initial, high-level review of the Cactus Project's potential and design options; there is no certainty that the 2024 PEA will be realized. For further detail on the Cactus Project and the 2024 PEA, including applicable technical notes and cautionary statements, please refer to the Company's press release dated August 7, 2024 and the 2024 PEA Technical Report, both available on the Company's website at and under its issuer profile at
Yahoo
2 hours ago
- Yahoo
Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania
STAFFORD, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the addition of clinical sites in Romania. The Company's application to expand Flamingo-01 into Romania has been formally approved by European regulators, thus adding Romanian sites to the approximately 150 approved sites in Spain, France, Germany, Italy, Poland and the US. At present, there are approximately 123 actively enrolling sites globally. According to the latest data collected by the European Cancer Information System (click here), a total of 12,861 new cases of breast cancer were diagnosed in Romania in 2022, which is the most common cancer diagnosed in women, representing approximately 28% of all cancers in women. Breast cancer is the leading cause of death from cancer in women in Romania with 3,877 deaths in 2022. The Company is collaborating with Dr. Nicoleta Antone, who is leading one of the largest academic breast cancer focused centers in Cluj Napoca, Romania, and her colleagues from at least 3 other sites in Romania. The Romanian clinical sites will be listed here with an interactive map. Dr. Antone will be serving as the national principal investigator in Romania for FLAMINGO-01. She is Head of Breast Cancer Centre at the Chiricuta Institute of Oncology in Cluj Napoca, Romania. She has been the Chair of the Romania Breast Cancer Group since 2021 and a member of the Women's Empowerment Cancer Advocacy Network since 2015. CEO Snehal Patel commented, "Romania is the first of several additional countries in Europe that we hope to add to Flamingo-01 as we now focus on mid-sized population countries with large population centers. We have visited the sites in Romania multiple times to assess study feasibility and provide training, and we are impressed with their facilities and commitment to the study. We look forward to working with Dr. Antone and her colleagues and have sufficiently advanced start-up activities this summer to be potentially screening and enrolling our first Romanian patients in the coming months." About FLAMINGO-01 and GLSI-100 FLAMINGO-01 (NCT05232916) is a Phase III clinical trial designed to evaluate the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2 positive breast cancer patients who had residual disease or high-risk pathologic complete response at surgery and who have completed both neoadjuvant and postoperative adjuvant trastuzumab based treatment. The trial is led by Baylor College of Medicine and currently includes US and European clinical sites from university-based hospitals and academic and cooperative networks with plans to open up to 150 sites globally. In the double-blinded arms of the Phase III trial, approximately 500 HLA-A*02 patients will be randomized to GLSI-100 or placebo, and up to 250 patients of other HLA types will be treated with GLSI-100 in a third arm. The trial has been designed to detect a hazard ratio of 0.3 in invasive breast cancer-free survival, where 28 events will be required. An interim analysis for superiority and futility will be conducted when at least half of those events, 14, have occurred. This sample size provides 80% power if the annual rate of events in placebo-treated subjects is 2.4% or greater. For more information on FLAMINGO-01, please visit the Company's website here and here. Contact information and an interactive map of the majority of participating clinical sites can be viewed under the "Contacts and Locations" section. Please note that the interactive map is not viewable on mobile screens. Related questions and participation interest can be emailed to: flamingo-01@ About Breast Cancer and HER2/ Positivity One in eight U.S. women will develop invasive breast cancer over her lifetime, with approximately 300,000 new breast cancer patients and 4 million breast cancer survivors. HER2 (human epidermal growth factor receptor 2) protein is a cell surface receptor protein that is expressed in a variety of common cancers, including in 75% of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. About Greenwich LifeSciences, Inc. Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2 protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75% of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. Greenwich LifeSciences has commenced a Phase III clinical trial, FLAMINGO-01. For more information on Greenwich LifeSciences, please visit the Company's website at and follow the Company's Twitter at Forward-Looking Statement Disclaimer Statements in this press release contain "forward-looking statements" that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as "anticipate," "believe," "contemplate," "could," "estimate," "expect," "intend," "seek," "may," "might," "plan," "potential," "predict," "project," "target," "aim," "should," "will," "would," or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Greenwich LifeSciences Inc.'s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including statements regarding the intended use of net proceeds from the public offering; consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section entitled "Risk Factors" in Greenwich LifeSciences' Annual Report on the most recent Form 10-K for the year ended December 31, 2024, and other periodic reports filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Greenwich LifeSciences, Inc. undertakes no duty to update such information except as required under applicable law. Company ContactSnehal PatelInvestor RelationsOffice: (832) 819-3232Email: info@ Investor & Public Relations Contact for Greenwich LifeSciencesDave GentryRedChip Companies 1-800-RED CHIP (733 2447)Email: dave@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
